Susquehanna Portfolio Strategies’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
FLAM
Susquehanna Portfolio Strategies's NEO Position: Q2 2024 in Review
Susquehanna Portfolio Strategies sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 73,234 shares — an estimated $1.15M sold.
Susquehanna Portfolio Strategies first reported a position in NEO in Q4 2023 and held it in 2 quarters. The position peaked at $2.72M in Q4 2023. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.
- Susquehanna Portfolio Strategies reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
- Susquehanna Portfolio Strategies sold 73,234 NeoGenomics shares in Q2 2024, an estimated $1.15M.
- Susquehanna Portfolio Strategies first reported a position in NeoGenomics in Q4 2023 and held it in 2 quarters.
- Susquehanna Portfolio Strategies's NeoGenomics position peaked at $2.72M in Q4 2023.
- 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.
Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2024, filed 15 Aug 2024.